Syner-KINASE® (urokinase) is licensed in the UK for the treatment of thrombosed catheters and systemic thromboembolic occlusive disease (diseases caused by blood clots).
Syner-KINASE® is available in the UK in vials of 10,000 IU, 25,000 IU and 100,000 IU.
The catheter lock dose is up to 25,000 IU per lumen and can be administered using the dwell-lock or push-lock technique.
Alternatively an infusion of up to 250,000 IU of Syner-KINASE® can be administered into the catheter over a period of 90 to 180 minutes.
Syner-KINASE® (urokinase) is the only urokinase in the UK free of human albumin
|Syner-KINASE® (urokinase) Patient Information Leaflet (PIL)||220.71 KB|
|Syner-KINASE® (urokinase) Summary of Product Characteristics (SPC)||202.6 KB|